Indegene IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
May 06 to May 08 2024
Price Band
₹430 - 452
Current GMP
₹655(44.91%)
Subscription
70.30 times
IPO Details
| IPO Date | May 6, 2024 to May 8, 2024 |
| Listing Date | Monday, May 13, 2024 |
| Face Value | ₹2 per share |
| Price Band | ₹430 to ₹452 per share |
| Lot Size | 33 Shares |
| Total Issue Size | 40,746,891 shares (aggregating up to ₹1,841.76 Cr) |
| Fresh Issue | 16,814,159 shares (aggregating up to ₹760.00 Cr) |
| Offer for Sale | 23,932,732 shares of ₹2 (aggregating up to ₹1,081.76 Cr) |
| Employee Discount | Rs 30 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 222,435,091 |
| Share holding post issue | 239,249,250 |
IPO Date
May 6, 2024 to May 8, 2024
Listing Date
Monday, May 13, 2024
Face Value
₹2 per share
Price Band
₹430 to ₹452 per share
Lot Size
33 Shares
Total Issue Size
40,746,891 shares (aggregating up to ₹1,841.76 Cr)
Fresh Issue
16,814,159 shares (aggregating up to ₹760.00 Cr)
Offer for Sale
23,932,732 shares of ₹2 (aggregating up to ₹1,081.76 Cr)
Employee Discount
Rs 30 per share
Issue Type
Book Built Issue IPO
Listing At
BSE, NSE
Share holding pre issue
222,435,091
Share holding post issue
239,249,250
IPO Subscription Details
| Anchor Investors | 1 |
| Qualified Institutions | 192.72 |
| Non-Institutional Buyers | 55.91 |
| bNII (bids above ₹10L) | 62.23 |
| sNII (bids below ₹10L) | 43.26 |
| Retail Investors | 7.86 |
| Employees | 6.62 |
| Total ** | 70.30 |
Anchor Investors
1
Qualified Institutions
192.72
Non-Institutional Buyers
55.91
bNII (bids above ₹10L)
62.23
sNII (bids below ₹10L)
43.26
Retail Investors
7.86
Employees
6.62
Total **
70.30
Day Wise Sub
| Day | QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|---|
| Day 1 May 6, 2024 | 0.05 | 4.25 | 1.56 | 1.41 | 1.70 |
| Day 2 May 7, 2024 | 5.45 | 18.44 | 3.94 | 3.40 | 7.44 |
| Day 3 May 8, 2024 | 192.72 | 55.91 | 7.86 | 6.62 | 70.30 |
DayDay 1
May 6, 2024
QIB0.05
NII4.25
Retail1.56
EMP1.41
Total1.70
DayDay 2
May 7, 2024
QIB5.45
NII18.44
Retail3.94
EMP3.40
Total7.44
DayDay 3
May 8, 2024
QIB192.72
NII55.91
Retail7.86
EMP6.62
Total70.30
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 13-05-2024 | 452.00 | 315(69.69%) | 767 |
| 12-05-2024 | 452.00 | 307(67.92%) | 759 |
| 11-05-2024 | 452.00 | 300(66.37%) | 752 |
| 10-05-2024 | 452.00 | 290(64.16%) | 742 |
| 09-05-2024 | 452.00 | 275(60.84%) | 727 |
| 08-05-2024 | 452.00 | 294(65.04%) | 746 |
| 07-05-2024 | 452.00 | 255(56.42%) | 707 |
| 06-05-2024 | 452.00 | 255(56.42%) | 707 |
| 05-05-2024 | 452.00 | 262(57.96%) | 714 |
| 04-05-2024 | 452.00 | 266(58.85%) | 718 |
| 03-05-2024 | 452.00 | 247(54.65%) | 699 |
| 02-05-2024 | 452.00 | 240(53.1%) | 692 |
| 01-05-2024 | 452.00 | 242(53.54%) | 694 |
| 30-04-2024 | 452.00 | 224(49.56%) | 676 |
| 29-04-2024 | 452.00 | 169(37.39%) | 621 |
Date13-05-2024
Price452.00
GMP315(69.69%)
Estimate List Price767
Date12-05-2024
Price452.00
GMP307(67.92%)
Estimate List Price759
Date11-05-2024
Price452.00
GMP300(66.37%)
Estimate List Price752
Date10-05-2024
Price452.00
GMP290(64.16%)
Estimate List Price742
Date09-05-2024
Price452.00
GMP275(60.84%)
Estimate List Price727
Date08-05-2024
Price452.00
GMP294(65.04%)
Estimate List Price746
Date07-05-2024
Price452.00
GMP255(56.42%)
Estimate List Price707
Date06-05-2024
Price452.00
GMP255(56.42%)
Estimate List Price707
Date05-05-2024
Price452.00
GMP262(57.96%)
Estimate List Price714
Date04-05-2024
Price452.00
GMP266(58.85%)
Estimate List Price718
Date03-05-2024
Price452.00
GMP247(54.65%)
Estimate List Price699
Date02-05-2024
Price452.00
GMP240(53.1%)
Estimate List Price692
Date01-05-2024
Price452.00
GMP242(53.54%)
Estimate List Price694
Date30-04-2024
Price452.00
GMP224(49.56%)
Estimate List Price676
Date29-04-2024
Price452.00
GMP169(37.39%)
Estimate List Price621
IPO Important Dates
| IPO Open Date | Monday, May 6, 2024 |
| IPO Close Date | Wednesday, May 8, 2024 |
| Basis of Allotment | Thursday, May 9, 2024 |
| Initiation of Refunds | Friday, May 10, 2024 |
| Credit of Shares to Demat | Friday, May 10, 2024 |
| Listing Date | Monday, May 13, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 8, 2024 |
IPO Open Date
Monday, May 6, 2024
IPO Close Date
Wednesday, May 8, 2024
Basis of Allotment
Thursday, May 9, 2024
Initiation of Refunds
Friday, May 10, 2024
Credit of Shares to Demat
Friday, May 10, 2024
Listing Date
Monday, May 13, 2024
Cut-off time for UPI mandate confirmation
5 PM on May 8, 2024
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,916 |
| Retail (Max) | 13 | 429 | ₹193,908 |
| S-HNI (Min) | 14 | 462 | ₹208,824 |
| S-HNI (Max) | 67 | 2,211 | ₹999,372 |
| B-HNI (Min) | 68 | 2,244 | ₹1,014,288 |
ApplicationRetail (Min)
Lots1
Shares33
Amount₹14,916
ApplicationRetail (Max)
Lots13
Shares429
Amount₹193,908
ApplicationS-HNI (Min)
Lots14
Shares462
Amount₹208,824
ApplicationS-HNI (Max)
Lots67
Shares2,211
Amount₹999,372
ApplicationB-HNI (Min)
Lots68
Shares2,244
Amount₹1,014,288
Financial Information
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 2,518.15 | 2,203.87 | 1,353.47 |
| Revenue | 1,969.75 | 2,364.10 | 1,690.50 |
| Profit After Tax | 241.90 | 266.10 | 162.82 |
| Net Worth | 1,327.00 | 1,063.72 | 763.90 |
| Reserves and Surplus | 1,282.65 | 1,019.43 | 763.55 |
| Total Borrowing | 399.33 | 394.34 | 18.24 |
Period EndedPeriod Ended
31 Dec 202331 Dec 2023
31 Mar 202331 Mar 2023
31 Mar 202231 Mar 2022
Period EndedAssets
31 Dec 20232,518.15
31 Mar 20232,203.87
31 Mar 20221,353.47
Period EndedRevenue
31 Dec 20231,969.75
31 Mar 20232,364.10
31 Mar 20221,690.50
Period EndedProfit After Tax
31 Dec 2023241.90
31 Mar 2023266.10
31 Mar 2022162.82
Period EndedNet Worth
31 Dec 20231,327.00
31 Mar 20231,063.72
31 Mar 2022763.90
Period EndedReserves and Surplus
31 Dec 20231,282.65
31 Mar 20231,019.43
31 Mar 2022763.55
Period EndedTotal Borrowing
31 Dec 2023399.33
31 Mar 2023394.34
31 Mar 202218.24
Key Performance Indicator
| Debt/Equity | 0.3 |
| RoNW | 18.23% |
| P/BV | 7.55 |
| PAT Margin (%) | 12.62 |
| EPS (Rs) | 11.96 |
Debt/Equity
0.3
RoNW
18.23%
P/BV
7.55
PAT Margin (%)
12.62
EPS (Rs)
11.96
IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 12,141,102 (29.78%) | NA |
| QIB Shares Offered | 8,094,069 (19.85%) | NA |
| NII (HNI) Shares Offered | 6,070,552 (14.89%) | |
| bNII > ₹10L | 4,047,034 (9.93%) | 8,759 |
| sNII < ₹10L | 2,023,518 (4.96%) | 4,379 |
| Retail Shares Offered | 14,164,620 (34.75%) | 429,230 |
| Employee Shares Offered | 296,209 (0.73%) | NA |
| Total Shares Offered | 40,766,552 (100%) |
Investor CategoryAnchor Investor Shares Offered
Shares Offered12,141,102 (29.78%)
Maximum AllotteesNA
Investor CategoryQIB Shares Offered
Shares Offered8,094,069 (19.85%)
Maximum AllotteesNA
Investor CategoryNII (HNI) Shares Offered
Shares Offered6,070,552 (14.89%)
Maximum Allottees
Investor CategorybNII > ₹10L
Shares Offered4,047,034 (9.93%)
Maximum Allottees8,759
Investor CategorysNII < ₹10L
Shares Offered2,023,518 (4.96%)
Maximum Allottees4,379
Investor CategoryRetail Shares Offered
Shares Offered14,164,620 (34.75%)
Maximum Allottees429,230
Investor CategoryEmployee Shares Offered
Shares Offered296,209 (0.73%)
Maximum AllotteesNA
Investor CategoryTotal Shares Offered
Shares Offered40,766,552 (100%)
Maximum Allottees
Information about company
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
The company's services can be divided into following categories
Enterprise Commercial Solutions
Omnichannel Activation
Enterprise Medical Solutions
Enterprise Clinical Solutions and consultancy services
The subsidiary of the company, DT Associates Limited, provides consulting services under the "DT Consulting" brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.
The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.
As of December 31, 2023, the company had 65 clients actively engaged with its services.
As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.
Objectives of IPO
The Company proposes to utilise the Net Proceeds towards funding the following objects:
Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.;
Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.; and
General corporate purposes and inorganic growth.
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App